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Abstract: Human Cytomegalovirus (HCMV) and Human Immunodeficiency 
(HIV) viral infection in pregnant patient is associated with high risk of 
maternal complications. This was a cross sectional study aimed to determine 
the prevalence and risk factors of HCMV and HIV mono-infections among 
230 pregnant women attending ante-natal clinic of Sobi specialist hospital 
Ilorin, Nigeria. Data of consenting participant was collected via interviewer-
administered questionnaire and clinical report form before collection of blood 
sample for analysis. The extracted serums were screened for HIV and CMV 
using rapid test-kits (Aleredetemine 
TM
HIV1/2) and ELISA for detection of 
anti-CMV IgG and IgM respectively. All 230 participants were negative to 
HIV infection while 97.8% and 3.0% was CMV IgG and IgM positive 
respectively. High positivity was recorded across all age group with 15-19 
having 100% anti-CMV IgG while the 25-29 and 30-34 years age group had 
highest anti-CMV IgM (P=0.907). 168(73.0%) of 171(74.3%) and 57(24.8%) 
of 59(25.7%) subjects within the parous and nulliparous group respectively 
were CMV-IgG positive while highest IgM positivity was noticed among the 
parous group (P=0.828). High CMV-IgG sero-positivity was also noticed 
across all level of education (P=0.700), marital status (P=0.668), types of 
marriage (P=0.008) and blood transfusion status (P=0.479). All the risk 
factors considered for HIV were very low while those for CMV had high sero-
positivity for both current and past infections. The high level of CMV among 
pregnant women noticed in this study could be responsible for the congenital 
infection among newborns prevalent in the study area. 
 





Human Cytomegalovirus (HCMV) is a 
member of the Betaherpesvirinae sub-
family of herpersviridae with HIV being 
a member of the genus Lentivirus and 
family Retroviridae [1]. CMV is a 
common viral pathogen affecting the 
bulk of the world’s populace by early 
middle age [2] with 50 to 80% of adults 
infected at 40 years [3]. Immuno-
competent individuals typically display 
no symptoms of infection [4] but in 
individuals with compromised immune 
system (immature and/or weakened) 
such as organ transplant or Acquired 
Immunodeficiency Syndrome (AIDS) 
patients, morbidity and mortality due to 
HCMV as a significant pathogen is 
hardly avoidable [5]. These individuals 
show different symptoms which include; 
spiking fever, leucopenia (decrease in 
white blood cell), malaise, hepatitis, 
pneumonia, gastrointestinal disease and 
retinitis [4]. HCMV is also to blame for 
just about 8% of infectious 
mononucleosis cases [6] and is also 
implicated in birth defects often leading 
to deafness and mental retardation in the 
foetus if the woman is infected during 
pregnancy [7]. 
 
The virus also spreads in households 
and young children in day care centers 
[8] with person to person transmission 
requiring close intimate contact with a 
carrier of the virus either in saliva, 
urine, or other bodily fluids, it can also 
be transmitted sexually, via breast milk, 
organ transplant and blood transfusion 
[9]. Cytomegalovirus (CMV) persists in 
the host for life [10] and recurrent 
infections are common during 
pregnancy constituting the majority of 
congenital infections in women with 
high prevalence of CMV-IgG [11]. 
 
In different populations, the sero-
prevalence of CMV-IgG among women 
of reproductive age ranges from 30% to 
100% [12] and the main influencing 
elements of CMV-IgG variability are 
geographical location, socioeconomic 
status (SES), the woman's age and parity 
and most importantly hygiene level [13]. 
The highest CMV-IgG sero-prevalence 
in pregnant women of 70–100% has 
been observed in Africa, Asia and South 
America [14] while pregnant women of 
developed countries have demonstrated 
lower CMV-IgG sero-prevalence levels 
of about 30–50% [15]. 
 
In HIV patients, HCMV reactivations 
and re-infections are common, and they 
are a major cause of  congenital 
infection in infants worldwide [16]. In 
most cases of CMV infection among 
healthy people, infection is usually 
asymptomatic, with few symptoms in 
some cases. Therefore, for the vast 
majority of individuals, CMV infection 
is harmless. In Lagos, Nigeria it was 
reported that 35(14.8%) patients: 
10(4.2%) males and 25(10.6%) females 
were positive for HCMV infection [17]. 
In Maiduguri, Nigeria it was reported 
that the sero-prevalence of anti-CMV 
IgG was 100% among HIV-infected 
patients. Having multiple sexual 
partners, traditional practices such as 
tattooing and cupping, and blood 
transfusion were significant risk factor 
among these cases [1]. 
CMV infection in pregnant women is of 
great concern because of their immune-
compromised state and risk of infection 
to the foetus whose immune system is 
not fully developed. The prevalence of 
CMV deduced from three locations in 
Nigeria namely Bida (84.2%), Lagos 
(97.2%) and Sokoto (98.7%) among 
pregnant women reveals that the 
infection is on the increase. This study 
aims to provide baseline information 
about HCMV and HIV co-infection 
among pregnant women attending ante-
natal clinic in the study area which will 
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help in management of the infection and 
prevent secondary spread.  
 
Materials and Methods 
Study Setting 
This research was conducted at the 
Ante-natal Clinic of Sobi Specialist 
Hospital Ilorin, Kwara State, Nigeria. 
Ilorin, the capital of Kwara State in 















Study Population and Sample Size   
The target population were pregnant 
women attending ante-natal Clinic of 
Sobi Specialist Hospital, Ilorin. The 
sample size derived using Fishers 
formula [19] was 230. 
 
Data and Sample Collection 
Interested participants were 
administered an informed consent form 
and a structured close ended 
questionnaire before collection of blood 
samples for analysis. 
 
Assay 
The blood samples were kept in an 
Ethylene Diamine Tetra-acetic Acid 
(EDTA) anti-coagulant., after collection 
via needle and syringe. This was 
centrifuged at 3000 r.p.m. for 5 minutes; 
the serum was harvested into clean 
sterile plain bottles using Pasteur pipette 
and pipette tips and then frozen at -20°C 
for assay.  
 
HIV assay 
HIV screening of the samples was 
achieved by using the rapid test kits 
(Aleredetermine
TM
 HIV1/2) following 
the manufacturers instruction. 
CMV assay 
Enzyme Linked Immunosorbent Assay 
method (ELISA) was used and it has  
been shown to be a sensitive and 
reliable procedure for detection of CMV 
antibodies with diagnostic sensitivity 
and specificity of 98% and ≥ 98% 
respectively (Rapid Labs Limited, UK). 
All samples were assayed for CMV-IgG 
and positive ones were further assayed 
for CMV-IgM to confirm current 
infections. 
The manufacturer’s conditions for valid 
assay were met and all the entire process 
was according to the manufacturer’s 








while test for statistical association was 
done using SPSS version 17.0. 
 
Ethical Considerations 
Approval for the study was obtained 
from Ethical Committee of Ministry of 
Health, Ilorin. Informed consents were 
obtained from patients and the study 
was at no cost to the subjects. 




Out of the 230 participants, no case of 
HIV infection was found and analysis of 
its risk factors showed that 7.83% had 
undergone surgery while most 
respondent (92.17%) had not, 4.8%  
have had tattoo as against those (95.2%) 
who did not, while few respondents 
(10.40%) had history of blood 
transfusion. Based on multiple sex 
partners, 22.10% of the population had 
multiple sex partners while 76.10% had 
single partners. 
 
From a total number of 230 samples that 
were screened for CMV-IgG, 225 
(97.8%) tested positive, 5 (2.2%) were 
negative and none was equivocal while 
IgM assay for CMV-IgG positive 
subjects results show that 7(3.1%) were 
positive, 217(96.4%) were negative and 
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All the 8(3.5%) subjects that were single 
and 217(94.3%) of 222 (96.5%) that 
were married tested positive CMV-IgG  
(P=0.668) while 6(2.7%) of 217(96.4%) 
married subject and 1(0.4%) of the 
8(3.6%) single subject were positive 
when assayed for CMV-IgM antibodies 
(P=0.293). The only equivocal result 
was recorded among the married 
women. 
 
The educational level of the respondent 
revealed that 9(3.9%) subjects without 
any form of education, 40(17.4%) of 
42(18.3%) that attended only primary 
school, 79(34.3%) of 81(35.2%) with 
secondary education and 92(40.0%) of 
93(40.4%) subjects that had tertiary 
education were all positive to CMV-IgG 
(P=0.700). Out of the 79 (35.1%) 
subjects in the secondary education  
 
group, only 1(0.4%) was positive while 
3(1.3%) of 40(17.8%) subjects in 
primary group and 3(1.3%) of 
92(40.9%) subjects in tertiary group 
were positive to CMV-IgM antibodies 
(P=0.373).  
 
The CMV IgG and IgM status of 
subjects in relation to the parity status 
revealed that 168(73.0%) out of 
171(74.3%) subjects within the parous 
group and 57(24.8%) of 59(25.7%) 
subjects in nulliparous group, tested 
positive to CMV-IgG (P=0.458) while 
results from CMV-IgM assay revealed 
that 5(2.2%) out of 168(74.7%) subjects 
within the parous group and 2(0.9%) out 
of 57(25.3%) subjects that are 
nulliparous were positive. One 
equivocal result was recorded among 
subjects in the parous group (P=0.828). 
 
Table 1: Cytomegalovirus IgG and IgM prevalence in relation to age 






















































            
































P value < 0.05 is statistically significant 
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Table 2: Sero-prevalence of CMV IgG and IgM in relation to marriage type of respondent 
 




    MONOGAMY POLYGAMY NO 
INDICATION 
   









































P value < 0.05 is statistically significant 
X2—chi square value 
 
 
Table 3: Sero-prevalence of cytomegalovirus in relation to blood transfusion of subjects 
 
 
value < 0.05 is statistically significant 




From this study, no case of HIV 
infection was found among the subjects 
and this could be due to low prevalence 
rate of HIV patient and its risk factors in 
the study location. Low prevalence of  
 
0.7% and 5.4% in other parts of Nigeria 
was reported [20] in Abeokuta (South 
western Nigeria) and [21] in Abakaliki 
(South eastern Nigeria). In  
  BLOOD RANSFUSION Total (%) P value X2 
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concurrence with this research, a study 
in Kabul [22] found no case of HIV 
infection in the 4,452 pregnant Afghan 
women and another in Malekan [23] 
also found no case of  
HIV infection in the 680 pregnant 
Iranian women. There is a wide 
geographical variation in the sero-
prevalence of HIV infection amongst 
pregnant women within and outside 
Nigeria. The variation may be a 
reflection of the differences in sexual 
practices and behaviour, awareness of 
HIV infection and status, socio-cultural 
practices, and accessibility to healthcare. 
The level of HIV awareness and status 
among this group is encouraging as risk 
of infection to the child is been checked. 
Among other risk factors to HIV 
transmission such as surgical procedure, 
tattoo practice etc, low blood transfusion 
level was also recorded and this is in 
contrary to a report [24] were pregnant 
women with history of blood transfusion 
had higher prevalence of HIV infection. 
Thus, it can be said that the transfusion 
in this case was thoroughly screened for 
HIV. Also, the population of 
respondents that share multiple sex 
partners was low which correlates to a 
report [25] that exposure to multiple sex 
partners has been found to be associated 
with increased risk of acquiring HIV 
infection. Another study [24] also 
reported that high prevalence of HIV 
among pregnant women can be linked to 
involvement with multiple sex partners.  
 
The results obtained from this study 
show that the sero-prevalence of 
Cytomegalovirus (CMV) infection 
among pregnant women in Ilorin, Kwara 
state is high with IgG 97.8% and IgM 
3.1% detected. The high prevalence 
rates could be due to lower  
 
 
socioeconomic status and poor hygienic 
conditions of the respondents in the 
study location. This result is in 
agreement with a study [26] that had 
prevalence rate of 97.2% among 
pregnant women in Lagos, Nigeria. Also 
in two similar studies, [27], [28] 
prevalence of 97.2% in Benin and 96% 
in Egypt were recorded respectively 
among pregnant women. However, in 
some European countries, low CMV 
infection rates have been reported, 
Australia (56.9%) and France (46.8%) 
[29]. The low prevalence rates in these 
countries could be due to the inclusion 
of CMV screening among the antenatal 
profile tests and better hygienic 
standards. The detected 97.8% of CMV 
infections in the current study showed 
that these women were at higher risk of 
HIV infections since the risk factors are 
similar. 
 
According to this study, the prevalence 
of CMV-IgG varied with age. The 
distribution of the age of the surveyed 
respondent showed that majority of 
respondent were aged 20-34years, 
accounting for 81.7% of the total 
participants and fewer percentages 
accounted for the older group. This is 
largely due to the fact that majority of 
pregnant women attending Ante-natal 
clinic belong to the child bearing age 
and are largely embedded in this age 
group. This statement conforms to study 
on changing pattern of cytomegalovirus 
sero-prevalence among pregnant women 
in Norway who reported that the highest 
CMV-IgG sero-positivity rate was 
detected in young women [30]. This is 
in contrast to other studies, reporting an  
increased CMV-IgG sero-prevalence 
with increase in age [31]. 
 
Evidence of current cytomegalovirus 
infection via IgM also supports that 




Olatunji, M. K. & Oluwajana E.                                                                                                  CJPL (2017)  5(1) 27-36 
 
because from the seven subjects with 
current infection (i.e IgM positive) as at 
the time of this research work four were 
below age 30 while three were below 
35. However, there was no statistical 
significant (P=0.907) between CMV 
infection and age of the respondent. 
From this study, it was observed that a 
larger percentage of study respondents 
were parous (73.0%) as compared to 
those that were nulliparous. However, 
there was no significant difference 
(P=0.828) to the risk of  
acquiring CMV infection between 
parous and nulliparous in the study. The 
result is similar to that reported [6] in 
Lagos state, which reported that there 
was no significant relatedness to the risk 
of acquiring CMV infection in the parity 
status of respondents to his study. 
Conversely, this in contrast to another 
research [29] in Kenya, which reported 
that there was a statistical correlation 
(P=0.0001) to the risk of acquiring 
CMV infection in the parity status 
correspondent to his study. According to 
the present data, it can be concluded that 
the risk of infectivity increases as the 
educational level gets higher because 
contact rate also increases which can be 
due to the low cleanliness level common 
across the group. It was also noticed that 
majority of the respondents in tertiary 
level were positive to cytomegalovirus 
IgG which may be due to the contact at 
earlier stages of education. This 
statement conforms to the report that 
illiterate women are at higher risk of 
CMV infection due to contact with 
contagious secretions from their own 
children and poor hygienic practice [32].  
However, analysis of the result by 
educational level shows that there was 
no significant association (P=0.373) 
between CMV infection and educational 
status. 
The percentage of marital survey shows 
that most of the respondents are married 
with only 3.5% of the population been 
single. Cytomegalovirus infection is 
higher in married women than in singles 
which suggest continuous circulation of 
the virus within the area and this 
conforms to a study that also recorded 
increased sero-positivity among married 
women than single ladies [26]. 
However, there was also no significant 
difference (P=0.294) in the transmission 
of CMV infection between those that 
were married or single in this study [17] 
which is in concordance with  another 
report that there was variation in 
prevalence of  HCMV in different 
marital status, but the variation was not 
statistically significant (P>0.05). The 
study showed (P=0.008) a significant 
association between Cytomegalovirus 
infection and type of marriage. With 
respect to the fact that majority of 
respondents claimed to be married, a 
vast majority of respondents were 
monogamous when compared to their 
counterparts whose marriage type was 
polygamous. The sero-prevalence of 
Cytomegalovirus was higher in women 
who had been involved in up to two 
marriages in their life time. This is in 
agreement with a research that states 
that the distribution of CMV sero-
prevalence among pregnant women by 
number of marriages shows that women 
who had been involved in up to three 
marriages in their life time had the 
highest sero-prevalence rate [33].  
 
There was no association between 
women who had been transfused and 
those that were not (P=0.479). The 
reason could be as a result of the
disproportionate size of women who 
were transfused to those who were not 
transfused enrolled in the study. This is 
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stated that past history of blood 
transfusion was found to be insignificant 
to the risk of acquiring CMV infection 
in his study but this statement is in 
contrast to a report that pointed blood 
transfusion as a risk factor for 
transmission of CMV infection [34]. 
Although most of the considered risk 
factors were not of statistical 
significance and there was no recorded 
case of co-infections, this study however 
shows that CMV is highly associated 
with pregnant women in Ilorin implying 
that there might be a corresponding 
increase in the incidence of congenital 
CMV infection among infant born in the 
state in form of CMV-related hearing 
loss, vision loss and poor mental  
 
 
development among children in Ilorin, 
Kwara state. Thus, increased public 
awareness  
about CMV and HIV infection is needed 
across Nigeria, and this can be done 
through primary health care channels 
such as antenatal clinics where the 
transmission, consequences of infection 
on foetus and its control and preventive 
measures can be discussed. Efficient 
blood screening for CMV and HIV 
before transfusion to pregnant women, 
routine screening of pregnant women 
for CMV should be adopted in all health 
care settings and babies born to sero-
positive mothers should be screened and 
examined immediately after delivery for 
possible signs of hearing and vision 
defect for early management. 
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